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Cellular immune control of HIV is mediated, in part, by induction of
single amino acid mutations that reduce viral fitness, but compen-
satory mutations limit this effect. Here, we sought to determine if
higher order constraints on viral evolution exist, because some
coordinately linked combinations of mutations may hurt viability.
Immune targeting of multiple sites in such a multidimensionally
conserved region might render the virus particularly vulnerable,
because viable escape pathways would be greatly restricted. We
analyzed available HIV sequences using a method from physics to
reveal distinct groups of amino acids whose mutations are collec-
tively coordinated (“HIV sectors”). From the standpoint of muta-
tions at individual sites, one such group in Gag is as conserved as
other collectively coevolving groups of sites in Gag. However, it
exhibits higher order conservation indicating constraints on the vi-
abilityof viral strainswithmultiplemutations.Mappingaminoacids
from this grouponto protein structures shows that combinedmuta-
tions likely destabilize multiprotein structural interactions critical
for viral function. Persons who durably control HIV without medi-
cations preferentially target the sector in Gag predicted to be most
vulnerable. By sequencing circulating viruses from these individu-
als, we find that individual mutations occur with similar frequency
in this sector as in other targeted Gag sectors. However, multiple
mutations within this sector are very rare, indicating previously un-
recognizedmultidimensional constraints onHIVevolution. Targeting
such regions with higher order evolutionary constraints provides a
novel approach to immunogen design for a vaccine against HIV and
other rapidly mutating viruses.
cytotoxic T-lymphocyte response | elite controllers | random matrix theory
Despite the efficacy of life-extending medications, HIV con-tinues to wreak havoc around the world, particularly in poor
nations. An efficient vaccine is urgently needed, and such a vac-
cine is likely to be one that induces both antibody and cytotoxic
T-lymphocyte (CTL) responses (1–3). The extreme variability of
the HIV envelope has precluded vaccine-induced generation of
broadly neutralizing antibodies (1) that can prevent acquisition,
leading some to focus on CTL-based vaccines (4) to prevent
disease progression and possibly to limit acquisition (5).
CTLs recognize and respond to viral peptides presented by
class I MHC proteins. Single point mutations within and sur-
rounding such HIV epitopes targeted by CTLs can enable escape
from immune pressure, leading to a focus on targeting conserved
regions of the HIV proteome. Conserved regions are defined to
be ones where the frequency of occurrence of mutations at single
sites is small, indicating [according to evolutionary theory (6)]
that the corresponding mutant viral strains are replicatively less
fit. Thus, if such a site is targeted, the outgrowth of a mutant
virus that escapes the immune pressure is less likely (7). The
emergence of a compensatory mutation that restores fitness is a
challenge to this approach (8).
Characterizing the frequency of occurrence of viral strains
based on the effects of mutations at single sites results in a unidi-
mensional measure of conservation, which ignores potential cou-
plings between the effects of multiple simultaneousmutations due
to structural/functional constraints. A useful multidimensional
measure of sequence variation would be obtained if groups of sites
in the viral proteome could be identified, such that sites within
a group coevolve in a collectively interdependent manner to in-
fluence virus viability but each group evolves independent of other
groups. If such groups exist, it is possible that a greater proportion
of the combinations of mutations involving sites in the group
are harmful in some groups compared with other groups. Such
a group of sites is multidimensionally more conserved in that
multiplemutations aremore likely to hurt virusfitness andharmful
combinations are less likely to be compensated for bymutations in
another group (as it coevolves independently). Such regions
should be particularly vulnerable to multiple points of CTL pres-
sure, because escape pathways would be restricted. Targeting
multiple points would promote the emergence of multiple muta-
tions to escape the immune pressure, but multiple mutations in
such a region would be more likely to result in unfit viruses.
Thus, we sought to determine collectively coevolving groups
of residues in HIV proteins. We analyzed publicly available se-
quences from the Los Alamos HIV Sequence Database (http://
www.hiv.lanl.gov/) of clade B HIV proteins derived from patients
with diverse genotypes using random matrix theory (RMT) (9) to
identify groups of sites (not pairs) that evolve collectively, pre-
sumably because they act together to perform a function im-
portant for the virus. RMT has been applied to diverse realms of
physics, to analyze stock price fluctuations (10, 11), and to ana-
lyze sequences of an enzyme (12). Although inspired by Halabi
et al. (12), we outline our analysis of HIV proteins by analogy
with analyses of financial markets.
From price fluctuations of various stocks over time, one can
compute the extent of correlation between changes in price of
a pair of stocks, averaged over all available time points. This yields
a matrix of pair correlations. Each element of the matrix describes
correlations between a particular pair of stocks, and mathematical
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properties of the entire matrix (Results) reveal groups of stocks
whose price fluctuations are collectively interdependent. These
properties of the matrix are influenced by “noise” because of a fi-
nite sample of times and correlations that reflect changes in
overall stock prices attributable to external forces (e.g., reces-
sions). RMT has been used to “clean” the correlation matrix of
these effects and obtain groups of companies whose economic
activities are intrinsically collectively coupled and essentially in-
dependent of others (10, 11). Consistent with intuition, each group
was composed of stocks that define known economic “sectors,”
such as financial service companies and automotive companies.
A similar analysis has enabled us to identify collectively
coevolving groups of sites in the HIV proteome (which we term
HIV sectors). Further, we have identified a sector in which
mutations at multiple sites are collectively more constrained, and
thus might be particularly vulnerable to multiple points of im-
mune pressure. We examined immune targeting and sequenced
circulating viruses in those rare persons who are able to control
HIV without medications to determine whether such mechanisms
might contribute to durable immune control. These data support
our predictions. We suggest how this new understanding can be
harnessed to design immunogens for a vaccine against HIV.
Results
Sequence Analysis Identifies Significant HIV Sectors. Each aligned
sequence of an HIV polyprotein is analogous to stock price data
at a particular time point. In a specific sequence, one asks if
a mutation away from the most frequent amino acid (“wild type”)
at a particular position i appears simultaneously with a similar
mutation at another site j, and this is done for all pairs of ami-
no acids. Average values for the frequency of occurrence of
double mutations for each pair of sites in the protein (fij for sites i
and j) are obtained by repeating this procedure for all sequences
(Methods and SI Appendix 1). Similarly, the frequencies with
which mutations are observed at individual sites (fi and fj for
sites i and j) are obtained. A pair correlation matrix, C, can be
A C D E
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Fig. 1. Defining collectively coevolving groups of sites (sectors) in Gag. (A, Upper) Number of eigenvalues (ordinate) of the correlation matrix, C, for Gag
(defined in the main text) with a given magnitude (abscissa) is shown. In total, 1,600 sequences of Gag polyproteins (500 residues long) were used. Note that
a relatively large number of sequences of HIV proteins are available. (Lower) Distribution of eigenvalues obtained from 1,000 randomly generated matrices of
the same size as C for Gag (described in the main text and SI Appendix 2). (B) Analyzing the eigenvectors corresponding to eigenvalues larger than the highest
eigenvalue for random matrices yields collectively coevolving groups of sites or “sectors” (SI Appendix 3–7). Sites within a sector are grouped together along
the rows and columns so that groups of collectively coevolving sites are vivid as squares along the diagonal of a heat map representing the values of the
correlations (obtained from the “cleaned” correlation matrix as described in SI Appendix 2). (C) Mean frequency of the dominant amino acid at single sites
within each of the five Gag sectors. (D–F) Threshold value defining a significant correlation was chosen to be such that correlations with magnitudes greater
than this value arise with vanishing probability in the randomized matrices (P < 0.02). Changing this threshold value does not change qualitative results (SI
Appendix, Fig. S11). (D) Percentage of significant negative (Cij < −0.03) pair correlations within each sector. (E) Percentage of significant positive (Cij > 0.1) pair
correlations within each sector. (F) Percentage of significant three-site negative (Cijk < −0.01) correlations within each sector (method in SI Appendix 17). (G)
Percentage of significant three-site positive (Cijk > 0.1) correlations within each sector.














defined, each element of which, Cij (for sites i and j), reflects
the interdependence of mutations at these two sites. Cij ¼




and measures the difference between the fre-
quency of occurrence of a double mutant and that which would be
observed if the two mutations occurred independently; the var-
iances of the distributions of mutations (Vi and Vj) at sites i and j,
respectively, normalize the values of Cij for different pairs of sites.
Another method (12) for computing Cij yielded qualitatively
similar results (SI Appendix, Fig. S6).
Properties of this correlation matrix, termed eigenvectors,
contain information about collective coevolution of sites. Each
eigenvector represents a specific combination of sites, whose
mutations occur in a coupled way but are essentially independent
of mutations in a combination of sites represented by another ei-
genvector. The data on HIV evolution can be represented as de-
pendent on these combinations of sites (eigenvectors), rather than
individual sites. The association of each site with a particular ei-
genvector is specified by a number that can be positive or negative.
An eigenvector is also associated with a number, called an eigen-
value, whose magnitude reflects the contribution of this eigen-
vector to the correlations between sites (SI Appendix, Eq. S4).
Eigenvalues of the correlation matrix, C, for HIV Gag poly-
proteins are shown ordered according to their magnitudes (Fig.
1A, Upper). The corresponding eigenvectors describe groups of
sites whose mutations are collectively linked, presumably by the
requirements of maintaining viral fitness. However, the infor-
mation in some eigenvectors is not significant because of noise
(attributable to a finite sample of sequences) or because it re-
flects phylogeny (13).
RMT theorems can help to determine which eigenvectors re-
flect the influence of noise because they describe the properties of
correlation matrices derived from independent random variables.
For example, given the length of the Gag polyprotein and the
number of available sequences, RMT states (SI Appendix, Eq. S3)
that the largest eigenvaluewould equal 2.4 if the correlationmatrix
reflected noise only. However, this theorem assumes that the
length of the polyprotein and the number of sequences are very
large. If we randomly shuffle the identity of amino acids at each site
over all aligned sequences of a particular HIV protein and recal-
culate C, we obtain a random correlation matrix of the same size
as our sample (SI Appendix 2). The distribution of eigenvalues
obtained by randomizing the sequences 1,000 times is shown in
Fig. 1A, Lower. We see that the RMT theorem is rather accurate
even for finite samples, because very few eigenvalues exceed 2.4
and none exceed 3. The continuous part of the eigenvalue spec-
trum for the real-sequence alignment forHIV proteins is bounded
in the same way as that for the randomized sequences (compare
panels in Fig. 1A for Gag). The eigenvectors corresponding to
eigenvalues <3 correspond to noise.
As noted before (12), and derived more completely in SI Ap-
pendix 3, the contribution of phylogeny alone to a representation
of the data in terms of eigenvectors should result in an eigenvector
where the contributions from each individual site in the poly-
protein have the same sign. For all HIV polyproteins, the largest
eigenvalue corresponds to such an eigenvector. Because each
eigenvector is independent, we conclude that the eigenvector
corresponding to the largest eigenvalue describes correlations
attributable to phylogeny (13). Eigenvectors corresponding to the
next few largest eigenvalues contain information on collective
correlations between groups of sites that originate largely from
relationships between evolutionary constraints and sequence.
By parsing these eigenvectors, groups of sites (sectors) in HIV
proteins that coevolve together but essentially independent of
others were identified. Many sites do not collectively coevolve
with any other sites, and thus do not belong to any sector. ForGag,
we found five strongly collectively coupled groups of sites (SI
Appendix 6 and Fig. S4), which we term sectors 1–5. As expected,
we also found an additional group of residues that is weakly
coupled collectively, as a result of mutations arising in the context
of specific HLA class I molecules that drive mutations at multiple
sites (SI Appendix 8 and Figs. S4 and S5). The weakly collective
linkage between this group of sites is attributable toHLA-associated
“footprints” [i.e., these mutations arise in persons with the same
HLA type (14)]; thus, we do not consider this quasi-sector further.
Gag sectors 1–5 can be visualized as a heat map reflecting the
correlations between sites (Fig. 1B). As expected, the sites that
comprise a sector are not contiguous along the linear protein
sequence. The positions of the sites along the rows and columns
in Fig. 1B group the sites in a sector together. For example, if
a sector was composed of sites 27, 45, and 53 along the linear
protein sequence, these sites would be adjacent to each other
along a row or column. Each group of sites that comprises
a sector is outlined in red. We observed similar groupings for other
HIV proteins (SI Appendix, Figs. S7–S10). We focus further
analysis on Gag because of data indicating correlations between
Gag-specific responses and viral control (15) and a strong impact
of Gag mutations on viral fitness (16).
Identification of an Immunologically Vulnerable Sector in Gag. From
the standpoint of identifying regions with single sites that are
more conserved, all five Gag sectors are equivalent (Fig. 1C).
However, if one examines the relative occurrence of positive and
negative correlations between multiple mutations at sites that
comprise each collectively evolving sector, differences between
the sectors become apparent.
Negative correlation between sites implies that the multiple
mutant is observed less frequently than if the individual mutations
were to arise independently. For example, consider a simple case
where a pair of sites (i and j) is negatively correlated, with each site
being 90% conserved [i.e., the frequency with which single muta-
tions at sites i and j are observed is 10%, (fi = fj = 0.1)]. For Cij
(proportional to fij − fifj) to be negative, the frequency with which
the double mutant is observed (fij) must be less than 1%. This
implies that when multiple sites are negatively correlated, the
multiple mutant is considerably less fit compared with the single
mutants. If immune pressure is applied tomultiple sites in a sector,
escaping the immune pressure is likely to require more than one
mutation. The greater the proportion of negative correlations in
the sector, the more difficult it is to both escape the CTL pressure
and maintain virus fitness, because multiple mutations are much
less tolerated, likely because of fitness limitations.
Positive correlation between sites implies that the corre-
sponding multiple mutants are observed more frequently than if
the mutations were to occur independently. Thus, positive cor-
relations can be associated with compensatory mutations; in-
deed, known compensatory mutations do appear as positive
correlations (SI Appendix, Table S9). Thus, sectors characterized
by larger numbers of positive correlations would be less effective
targets, because escape from CTLs without substantial loss in
virus fitness is more likely.
For pairs of sites within a sector, one finds that Gag sector 3
contains the largest proportion of negative correlations compared
with other sectors and a relatively small number of positive cor-
relations (Fig. 1 D and E). This is also true for three-site (Fig. 1 F
and G) and higher order correlations. The magnitudes of the
negative pair correlations between sites in sector 3 are as large
as they can be, given the level of single site conservation in this
sector (details in SI Appendix 11), meaning that the doublemutants
are expected to be observed very rarely. The eigenmaps in SI Ap-
pendix, Fig. S4 B and C also show that several sites in sector 3 are
collectively (i.e., at higher order) negatively correlated to several
others, which is not true for other sectors. Note that we do not
identify important negative pair correlations by screening all pair
correlations for those that exceed a cutoff (17). Rather, we first
identified groups of sites (sectors) that are significantly collectively
coupled (because RMT theorems help to eliminate noise-induced
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correlations). We then examined the signs of multibody corre-
lations only within these meaningful collectively coupled sectors.
Our results suggest that sector 3 is the most immunologically
vulnerable multidimensionally constrained region in Gag, be-
cause multiple mutations are most constrained in this sector.
Because sequence analysis methods are not exact, we tested this
prediction, and its consequences for HIV infection and vacci-
nation, against existing and new experimental data.
Sector 3 Is Immunologically Vulnerable Because of the Importance
of Assembling Multiprotein Structures Critical for Viral Capsid
Formation. In sector 3, 52 of the 57 sites are contained in the p24
protein but their locations within an individual p24 protein appear
random (Fig. 2A; individual amino acids in SI Appendix, Table
S1). However, hexamers of the p24 protein form the viral capsid
(18), and superimposing sector 3 sites on the structure of the p24
hexamer (19) shows that the preponderance of these sites (∼68%)
is at interfaces between p24 proteins in a hexamer or at interfaces
between the hexamers that form the capsid (Fig. 2B). Coevolution
of this group of sites originates from constraints important for
assembly of functional multiprotein structures, highlighting the
importance of determining collective correlations.
The structural locations of sector 3 sites suggest the origin of
negative correlations. Whereas one mutation in interface residues
may still allow formation of p24 hexamers and assembly of the
hexamers to form the viral capsid,multiple simultaneousmutations
would likely destabilize these protein-protein interfaces. Fitness
cost predictions ofmultiple mutations in sector 3, and comparisons
with available data (20), are included in SIAppendix, Table S9–S11.
Sector 1 sites also reflect structural constraints associated with
supramolecular assembly because they largely comprise the core
of the hexamer (Fig. 2C). However, our analyses suggest that
sector 1 is not as immunologically vulnerable as sector 3. This is
because of the following:
i) The ratio of negative to positive correlations for pairs of
mutations is a factor of 3 greater for sector 3.
ii) At the level of three-site correlations, the ratio of negative
to positive correlations is more than threefold greater for
sector 3.
iii) Sector 3 is characterized by collective higher order negative
correlations between sites that are absent in sector 1 (SI
Appendix, Fig. S4).
These results may be because multiple mutations in sector 3
residues result in disruption of intra- and interhexamer inter-
faces, whereas mutations in the core of the hexamer are less
likely to disrupt virion assembly (21).
Elite Controllers of HIV Preferentially Target Multiple Sites in Sector 3.
Our results suggest that applying CTL pressure at multiple sites
contained in sector 3 is likely to facilitate durable control of viral
load to low levels; multiple mutations that allow immune escape
are more likely to hurt viral fitness significantly, because multidi-
mensional escape pathways are restricted. Can HLA (human
MHC class I) molecules present peptides containing multiple sites
within the identified vulnerable region? Because elite controllers
achieve viral control (16), we first analyzed the locations of sites
contained in peptides targeted in individuals with HLA alleles
associated with spontaneous HIV control (HLA-A*25, B*57,
B*27, B*14, Cw*08) (22). Remarkably, the sector with the largest
proportion of sites contained in the dominant peptides targeted by
controllers is sector 3 (P= 3·10−7; Fig. 3A and SI Appendix, Table
S3). CTL pressure imposed by individuals with these HLA alleles,
however, is not the driver of this collectively coevolving group of
sites for reasons that include:
i) There are clear structural explanations (Fig. 2) for the col-
lective correlations that characterize sector 3 sites, and
structural features are independent of immune pressure.
ii) Negative correlations cannot be induced by immune pres-
sure, because mutations induced in persons with the same
HLA would be more likely to arise than if they occurred
independently.
iii) As noted, a quasi-sector describes weak correlations associ-
ated with HLA-associated mutations (SI Appendix, Fig. S5),
and these sites are not a part of sector 3.
Thus, the sector we identify to be most vulnerable by analyses
of viral sequences and supramolecular structures is the most
targeted by controllers.
Examining targeted epitopes lends further insights. For ex-
ample, eight amino acids in the dominant epitopes targeted by
B57-restricted CTLs are in sector 3; this multiplicity is further
augmented by the enhanced cross-reactivity of these CTLs (23).
B14+ individuals target three amino acids in this sector. Popu-
lation studies indicate that HLA-B57+/B14+ persons are partic-
Fig. 2. Protein structures reveal the origin of collective correlations. (A) Sector 3 sites represented on the structure of the p24 monomer (PDB ID code 3GV2)
are shown as purple spheres. (B) Sector 3 sites represented on the structure of the p24 hexamer (PDB code 3GV2) and the structure of the interface between
hexamers (PDB code 2KOD). Sites at interfaces between two p24 proteins belonging to two adjacent hexamers are shown in green, and sites at interfaces
between two p24 molecules within a hexamer are shown in red. The few remaining sites in sector 3 that are not part of these interfaces are shown in purple.
(C) Sector 1 sites are shown in cyan on the structure of the p24 hexamer.














ularly efficient controllers of HIV infection. Our results suggest
that this is because viral strains that can escape the multiple
points of immune pressure in this sector are likely to have very
low fitness. Thus, point mutants with lower viral fitness that only
partially escape immune pressure or strains with multiple muta-
tions that are not negatively correlated are likely to be the only
options for the virus. This is consistent with the observed lower
viral load and lower average viral fitness in controllers (16). Note
also that CTLs restricted by HLA molecules associated with
progression do not target sector 3 sites significantly (P = 0.37;
SI Appendix, Table S3).
Virus Sequences from Patients Show That Multiple Mutations in
Sector 3 Are Unlikely. Roughly 10% of sites in sectors 1, 4, and 5
are targeted by controllers, and sector 2 is not targeted (Fig. 3A).
However, because sectors 4 and 5 are composed of only 10 and
14 sites, respectively, only 1 site (and epitope) is targeted by
controllers in these sectors. Because sector 1 comprises 79 sites,
many sites in sector 1 are targeted by controllers. If two regions
of the proteome are equally targeted, all things being equal, the
number and types of mutations observed in these regions should
be similar. Sectors 1 and 3, both in Gag, exhibit similar levels of
single site conservation, but we find that sector 3 is more mul-
tidimensionally constrained. Thus, we predict that even though
sector 3 is targeted more than sector 1, fewer HIV strains with
multiple mutations in sector 3 sites would be viable compared
with those with similar mutations in sector 1.
To test this prediction, we sequenced viruses obtained from
elite controllers because they target both sectors 1 and 3. We
obtained 72 sequences from plasma and 103 including both
plasma and peripheral blood mononuclear cells (PBMCs). The
qualitative results obtained from analyzing either set of se-
quences are the same (Fig. 3B and SI Appendix 18). As per our
predictions, the frequency of single mutations in sectors 1 and 3
is similar but multiple mutations are significantly rarer in sites
that comprise sector 3. Our results suggest that this is because
viral strains that can escape multiple points of immune pressure
in sector 3 are more likely to be associated with negative cor-
relations, and hence have particularly low replicative fitness be-
cause of defective capsid assembly. Thus, they are unlikely to be
viable, and we do not observe them. These results show that the
calculated differences between collective correlations among sites
that comprise sector 3 and other sectors (Fig. 1) result in quali-
tative differences in viral mutations observed in humans that
target sector 3 sites. Note also that almost all the few viral strains
that we observe with multiple mutations in sector 3 are associated
with positive correlations (SI Appendix, Fig. S13). Although only
positive correlations can correspond to compensatory mutations,
positive correlations can also correspond to multiple mutants
that are only moderately less fit compared with single mutants,
unlike negative correlations, which are only associated with
multiple mutants that are very deleterious.
Our results strongly support our hypothesis that applying CTL
pressure at multiple points in a multidimensionally constrained
group of sites can trap the virus, because we find that controllers
target multiple sites in sector 3, but strains with multiple muta-
tions in sector 3 are not viable. Thus, viable strains are still likely
to be subject to immune pressure.
Immunogens That May Induce CTL Responses in a Population That
Hurt HIV. Can such potent responses be induced by vaccination in
persons who are not blessed with HLA alleles that mount the
correct dominant responses? Individuals with other HLA alleles
present subdominant peptides containing sites in the vulnerable
regions we have identified (using the Epitope Tables of the Los
Alamos HIV Molecular Immunology Database, http://www.hiv.
lanl.gov/content/immunology/tables/tables.html). This suggests the
following strategy for design of immunogens that could induce
memory CTL responses targeting the most vulnerable regions of
HIV in a population: Select protein segments that simultaneously
maximize sites in sector 3 (and some sites in sector 1), which are
characterized by negative correlations, and those contained in
subdominant and dominant epitopes presented by HLAmolecules
that span a broad section of a population. Such immunogens
should elicit memory CTLs that only target the multidimensionally
conserved regions of HIV, because epitopes that are dominantly
targeted ineffectually are excluded. During natural infection, these
memory CTLs are expected to mount robust responses that hit
HIV where it hurts early, before naive CTLs mount ineffective
dominant responses. Mounting the right responses early is im-
portant for HIV infections (2), because there is a short window of
time before the immune system is compromised.
To illustrate this strategy, we considered a target population,
white Americans with the 25 most frequent haplotypes (∼39% of
this population) (24). We create all groups of 10 known epitopes
(as an example) presented by HLA-A/B molecules that comprise
these haplotypes and select the top 10 groups according to the
two criteria noted above (SI Appendix 12). One top-scoring im-
munogen (p24 residues 160–188 and 240–277) contains at least 1
or 2 targeted epitopes in 97% and 56% of the target population,
respectively (a lower bound, because many epitopes are un-
known). Previous empirical data show that controllers target p24
sites 240–272 (25). Sites 160–188 contain only 1 epitope tar-
Fig. 3. Concentration of sites from the dominant epitopes presented by
elite controllers in each sector and comparison of mutation patterns in
sectors 1 and 3 in viruses derived from elite controllers. (A) Epitope is defined
as dominant if it is the most targeted (in Gag) by individuals with the cor-
responding HLA allele. Concentration is the number of epitope sites in the
sector divided by the total number of residues in the sector. The P value of
association with each sector is in SI Appendix 10. Only sector 3 is significantly
enriched with sites from the dominant epitopes of HLA molecules associated
with control. Sectors 4 and 5 are not targeted at multiple points because
they contain only 10 and 14 sites, respectively. Sectors 1 and 3 are targeted
at multiple points. (B) Comparison of the number of unique viral strains
obtained from a cohort of elite controllers that contains different numbers
of mutations in sectors 1 and 3.
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geted by known controllers but represent an equally vulnerable
region that provides broad coverage.
Discussion
Immunogens designed in this way to include only the multi-
dimensionally constrained regions of the HIV proteome, which
also contain epitopes presented by diverse HLAs in a population,
are candidates for peptide vaccines using synthetic vectors (26),
or by linking each segment together, they can be analogs of
mosaic immunogens (27) delivered by traditional vectors. Such
an immunogen would target the most vulnerable regions of HIV
rather than the whole proteome. Targeting the latter is more
likely to elicit responses from which HIV can escape via muta-
tions (28), while hindering a focused response directed at regions
of immunological vulnerability we have identified. Our goal of
identifying such regions, and the methods we have used toward
this end, are different from previous efforts to study coevolution
of HIV proteins (e.g., 14, 29–31). Further analysis following the
logic described by us should reveal additional regions of HIV
proteins that are multidimensionally constrained, thereby en-
hancing the list of regions that are candidates for inclusion in
a potent vaccine. A practical vaccine may also require inclusion
of CD4 epitopes and flanking residues needed for antigen pro-
cessing which do not contain protein segments that are likely to
elicit ineffectual memory CTL responses. In vitro experiments
and studies with animal models are required to develop this
new concept, which might also be applied to design efficacious
immunogens against other viruses. Our results also suggest the
design of new small-molecule inhibitors of HIV replication.
Methods
HIV Sequences and Similarity Analysis. Multiple sequence alignments of nu-
cleotide sequences of HIV-1 Gag, RT, and Nef were downloaded from the Los
Alamos HIV Sequence Database (http://www.hiv.lanl.gov/) (clade B, one se-
quence per patient). We checked the phylogenetic homogeneity of each set
by performing a principal component analysis of the similarity matrix of
sequences (SI Appendix 5).
Identification of HIV Sectors. The correlation matrix for a given set of
sequences is cleaned from phylogeny and noise using RMT (as described in the
main text and SI Appendix 1–4). The definition of sectors follows the strategy
proposed by Halabi et al. (12), grouping positions with a particular spectral
signature into a sector (SI Appendix 6).
Targeting by Elite Controllers. We defined a set of epitopes dominantly tar-
geted by HLA alleles associated with control (22), using a published dataset of
the frequency of recognition of epitopes in an HLA-specific population (32).
Sequencing Viruses from Elite Controllers. HIV-1 Gag was amplified using
nested RT-PCR from previously frozen PBMCs or plasma from elite con-
trollers as previously described (33). PCR products were purified, and cycle-
sequencing reactions were performed using 60 HIV-1–specific sequencing
primers. Population sequences were obtained using an ABI 3730 PRISM
(Applied Biosystems) automated sequencer. Gag mutations in the sequences
derived from elite controllers were defined with reference to the clade B
consensus sequence.
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immunologic vulnerability’ (2011) 1. Definition of the correlation matrix For each position i of a given protein or polyprotein, the type of amino acid in each sequence s of the Multiple Sequence Alignment (MSA) is represented by a binary variable , where   if the amino‐acid is the most frequent amino acid at this position within the MSA, and   if it is another amino acid (binary representation). Since different positions have different levels of conservation (standard deviation of  ), we define a normalized cross‐correlation matrix C, with elements:  
   (S1) 











      (S4) Here,   is the kth eigenvector. The first sum in Eq. S4 is usually negligible, and the second term is dominated by noise‐induced correlations. Therefore, the noise‐cleaned correlation matrix  reads 
    (S5) 
RMT bounds are defined for infinite M and N. In order to assess finite size effects, the distribution of eigenvalues for independent random variables can be determined numerically. For instance, in the case of a MSA represented by a set of binary variables, one can remove the real correlations between   and   by randomly permuting the values of   across different sequences s.   For example, if there were only 3 sequences in the MSA, and a particular position had A, F, L as the amino acids in the 3 sequences, one random permutation would be F, L, and A.  For our study of the 500 amino acid polyprotein Gag, 1600 sequences were used, giving theoretical values2 (infinite size limit, Eq. S3):  and . We performed 1000 permutations at each position to obtain 1000 randomized alignments. The distribution of the 500 000 obtained eigenvalues is shown in Fig. 1A (bottom spectrum). The higher edge of the distribution is (as expected) somewhat different than the asymptotic value of  + = 2.42, but there is no eigenvalue above 3.   Therefore, information contained in eigenvalues less than 3 are considered to be corrupted by noise. The eigenvalue spectrum of the matrix C obtained for the real alignment of Gag is shown in Fig. 1A (top spectrum). Fourteen eigenvalues are higher than the noise threshold of 3. Those eigenvalues contain information corresponding to non‐random correlations between the positions.  The principle of Random Matrix Theory can be similarly applied to the SCA correlation matrix1, although in that case, no analytical formula for the bounds of the eigenspectrum is available. Since the properties of Random SCA Matrices are not as well defined as those of Random Correlation Matrices, we decided to analyze the data with the latter method. We checked that the results were qualitatively similar using the SCA correlation matrix (see S9). 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3. The spectral contribution from phylogeny The phylogenetic relationship4 between the different sequences of the MSA can also give rise to correlations. To understand this, let us consider the evolution of a hypothetical protein with N amino acids that mutate independently of each other. We further assume that the binary approximation holds, wherein each site on the protein may take on one of two values (1 and 0). Let   and   represent the probabilities that the residue occupying site i is ‘1’ and ‘0’ respectively at time t. Using the conservation relation , we can describe the time evolution of the probability  for each site by the master equation,  
         (S6) 
Here,   and   are the mutation rates from state ‘1’ to state ‘0’ and vice‐versa. These rates are the same for all N positions because of our assumption that the mutations at each position are independent. We assume an initial condition   = 1 for all sites i. In this simple toy‐model, the uniform initial condition represents phylogeny.  The solution to Eq. S6 is,          (S7) 
Here, for simplicity, we consider that we have an infinite number of sequences sampled uniformly between the times t=0, and t=T. We compute the correlation function between two positions i and j  
     (S8)    
Since we consider all sites to be independent,   and in Eq. S8 have identical expressions. Substitution of Eq. S7 in Eq. S8 and a little algebra yields,  
 
                  (S9) 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As  ,  , but  is non‐zero for finite times T. Therefore, despite mutations at each site occurring independently, the presence of a common initial condition (i.e. phylogeny) contributes to a non‐zero correlation between positions if we consider sequences that have evolved for finite times. If we sample sequences that have evolved for infinitely long times, however, this correlation vanishes as one would expect as the sequences have lost memory of the ancestral sequence – i.e, they are no longer phylogenetically related.  That phylogeny will contribute to a coherent mode in the correlation matrix can be illustrated using this simple calculation.  Consider the  x correlation matrix C for the hypothetical protein of chain length N. If each site evolves independently of others, C is a matrix of identical elements, each of which is equal to  in Eq. S9. 
C has rank unity and its only non‐zero eigenvalue is  . This is a consequence of the Perron‐Frobenius theorem in Linear Algebra5. The corresponding eigenvector is  , which is a coherent mode.   

















Sector 1 Sector 2 Sector 3 Sector 4 Sector 5 Q-Sector 
1 88 23 446 53 305 166 17 18 
2 94 37 450 140 306 197 31 30 
3 97 178 452 163 310 211 47 54 
4 99 379 455 167 316 222 137 62 
5 100 381 457 169 317 236 161 69 
6 108 386 459 170 319 237 261 90 
8 118 391 461 171 323 308 275 125 
9 120 392 462 172 326 318 278 130 
11 122 393 463 174 338 354 290 146 
12 123 394 464 175 344 396 298 147 
14 128 395 489 179 345   324 159 
16 129 399   180 346   334 173 
19 131 400   181 347   337 176 
20 133 402   182 363   343 200 
21 134 405   185 364     218 
24 135 406   186 365     219 
27 136 407   187 366     223 
29 138 408   189 367     224 
32 139 412   191       228 
33 141 413   198       230 
35 142 414   199       234 
36 143 416   212       242 
38 144 417   221       248 
39 145 419   225       252 
41 148 420   229       255 
45 149 423   233       256 
48 150 430   240       264 
50 151 431   243       267 
51 152 432   245       268 
52 153 434   249       273 
57 154 435   257       280 
60 155 437   260       281 
63 156 438   263       286 
73 158 439   265       312 
77 160 440   269       341 
79 251 442   284       357 
83 276 443   288       362 
86 279 444   291       374 
87 433 445   295       375 
                376 
                401 
                403  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Table S2. List of the epitopes of each group. Group 1 contains the most frequently recognized Gag epitopes in acute and in chronic phase, while the group 2 contains all epitopes that are recognized by more than 20 percent of the population carrying the specified HLA allele.    Epitope group 1  Epitope group 2 A25  QW11  QW11, EW10 B57  TW10, KF11  TW10, KF11, IW9 B27  KK10  KK10 B14  DA9  DA9 
HLA alleles associated with control 
Cw8  RV9, TL9   A29  LY9  LY9 B07  GL9  GL9 B08  EI8  EI8 




Here  is the number of residues in Gag ( ),   is the number of residue in the sth sector,   is the total number of residues of the considered epitopes,   is the number of those  residues in the sth sector. The results are presented in the tables S3 and S4.  
Table S3. p‐value of association  , and “non‐association”   of the residues from group 1 epitopes with the different Gag sectors.  is the number of residue in the sth sector,  is the number of  epitope residues in the sth sector.     “Controllers”  “Progressors” Sector               1  79  9  0.78  0.33  7  0.56  0.61 2  51  0  1.0  6.0 10‐4  1  0.99  5.3 10‐2 3  57  24  3.0 10‐7  1.00  6  0.37  0.77 4  10  1  0.75  0.60  0  1.0   0.41 5  14  1  0.86  0.42  2  0.35  0.87 Quasi‐Sector  42  8  0.22  0.88  6  0.16  0.93 non‐sector  247  26  0.98  3.3 10‐2  22  0.53  0.59   11. Strength of negative correlations Within the binary approximation, for a given value of the frequencies fi and fj of the most abundant amino‐acid at two sites i and j, one can compute the minimum value of the correlation coefficient  .  The minimum value is obtained when the frequency of the double mutant is equal to zero (possible if fi + fj >1). In that case, one can easily show: 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  
f ij = f i + f j −1         (S15) and then, 
  
Cij = fi + f i −1− f i f j( ) / ViV j = − 1− f i( ) 1− f j( ) / fi(1− f i) / f j (1− f j ) = − (1− fi)(1− f j ) / f j f i                      (S16) The absolute value of this number is smaller when the frequencies are larger, i.e. when the two residues are more conserved. For example, for fi = fj =0.95, we get a minimum value of ‐0.052. As a comparison, in the case fi = fj, the maximum value of  is 1. 
Table S4. p‐value of association  , and “non‐association”   of the residues from group 2 epitopes with the different Gag sectors. 
 As a consequence, the strength of a negative correlation cannot be as high as the strength of positive correlations.  In all the cases we have considered as highly negatively correlated (  < ‐0.03 in Fig. 1d), the value of   is actually equal to this limit. It means that for those pairs, the correlation coefficient could not be more negative. However, from a statistical point of view, the probability that the correlation coefficient between two residues reaches this limit for many such pairs, as is the case in sector 3, is quite high. As an illustration, let’s consider 2 conserved residues, i.e fi = fj =0.96, and a sample of 1000 sequences. It means that there are 40 mutants at site i and 40 mutants at site j over the 1000 sequences. If the two residues evolve 
    “Controllers”  “Progressors” Sector               1  79  17  4.3 10‐2  0.98  3  0.80  0.39 2  51  0  1.0  5.4 10‐4  0  1.0  6.1 10‐2 3  57  16  4.8 10‐3  1.0  4  0.34  0.83 4  10  2  0.41  0.84  0  1.0  0.59 5  14  1  0.86  0.41  1  0.52  0.84 Quasi‐sector  42  8  0.23  0.87  4  0.17  0.94 non‐sector  247  26  0.99  2.6 10‐2  14  0.40  0.74 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Combination Ep. 1 Ep. 2 Ep. 3 Ep. 4 Ep. 5 Cov. DCov. 
1 167-175 180-188 259-268 260-267 260-269 0.578 0.304 
2 167-175 180-188 240-249 260-269 291-300 0.696 0.162 
3 167-175 180-188 240-249 260-269 308-316 0.414 0.116 
4 160-168 167-175 180-188 260-269 261-270 0.365 0.059 
5 167-175 180-188 240-249 260-269 261-270 0.414 0.059 
6 167-175 180-188 254-262 260-269 261-270 0.425 0.059 
7 167-175 180-188 240-249 259-268 260-269 0.638 0.038 
8 167-175 180-188 240-249 260-267 260-269 0.638 0.038 
9 167-175 180-188 240-249 260-267 261-270 0.638 0.038 
10 167-175 180-188 240-249 260-269 306-316 0.529 0.038 
11 167-175 180-188 240-249 260-267 306-316 0.723 0    
  19 
Table S6. 11 combinations of 10 epitopes (Ep.). The numbers correspond to the Gag HXB2 numbering of amino acid positions. The coverage (Cov.) is the frequency of haplotypes that are known to present at least one of those 10 epitopes, within the Hardy‐Weinberg approximation, and among the 25 most frequent haplotypes in the Caucasian American population. The double coverage (DCov.) is the frequency of those haplotypes known to present at least two of those 10 epitopes. 










Sector 1 Sector 2 
6 88 13 118 
59 127 25 119 
60 128 36 121 
61 144 37 122 
62 164 43 123 
65   45 124 
66   48 130 
67   49 131 
68   50 132 
69   51 134 
70   54 136 
72   56 137 
73   91 139 
74   106 140 
75   109 141 
76   110 145 
77   111 146 
78   112 157 
79   113 169 
84   115 176 

































8-153 -0.016 -0.062 
11-63 -0.028 -0.057 
11-86 -0.023 -0.069 
12-138 -0.037 -0.052 
16-141 -0.017 -0.076 
24-52 -0.016 -0.068 
24-87 -0.011 -0.053 
24-134 -0.014 -0.059 
24-160 -0.017 -0.063 
38-138 -0.037 -0.095 
41-144 -0.018 -0.061 
63-97 -0.015 -0.081 
63-149 -0.019 -0.051 
94-141 -0.067 -0.063 
97-138 -0.045 -0.066 








   17. Evaluation of three‐site correlations   Three‐site correlations reflect the way two mutations influence the probability of a third mutation. In order to evaluate 3‐body correlations within each sector, we computed the correlation function between variables  and variables : 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